World Aquaculture Singapore 2026

June 2-5, 2026

Singapore

GENOME EDITING IN AQUACULTURE: GLOBAL REGULATORY TRENDS AND THE PATH TO COMMERCIALIZATION

Debbie Plouffe*

 

Center for Aquaculture Technologies, San Diego, CA, USA; dplouffe@aquatechcenter.com



Genome editing is emerging as a powerful  tool for genetic improvement in aquaculture, with the potential to provide solutions to key  challenges that emerge as the industry continues to scale.  These opportunities include reducing incidence and severity of diseases and creating improvements in productivity, overall animal welfare, and environmental sustainability. However, questions around regulatory oversight and market access continue to influence the pace of adoption.

 This presentation provides an overview of the global regulatory landscape for genome editing in aquaculture, with a focus on site-directed nuclease-1 (SDN-1) approaches that do not introduce foreign DNA. These edits are indistinguishable from naturally occurring genetic variation or outcomes achievable through conventional breeding. As a result, a growing number of countries are adopting risk-based regulatory frameworks that distinguish genome editing from traditional transgenic genetically modified organisms (GMOs), enabling more streamlined or exempt regulatory pathways.

Drawing on direct engagement with regulatory agencies and ongoing industry projects, we highlight key trends across major seafood producing and consuming regions, including examples of countries where clear regulatory pathways are already in place. We also discuss how these developments are shaping the commercial outlook for genome edited products in aquaculture.

Finally, the presentation outlines practical considerations for industry stakeholders, including early regulatory engagement, trait selection aligned with industry and societal priorities, and transparent communication strategies. Together, these elements support a responsible and commercially viable pathway for the adoption of genome editing in aquaculture.